John Climaco

John Climaco has a significant amount of work experience in various roles and companies. John is the Chairman and Chief Executive Officer of CNS Pharmaceuticals, Inc., a clinical-stage biotechnology company specializing in brain tumor treatments. John also held the role of Director at Moleculin Biotech, Inc.

Prior to that, they were a Director at Digirad and Perma-Fix Environmental Services. John served as the Executive Vice President at PermaFix Medical, S.A., where they were involved in developing a new method of producing medical radioisotope Technetium 99m.

John Climaco has also worked as a Director at PDI, Inc. and InfuSystem, Inc. Additionally, they co-founded and served as the CEO of Axial Biotech, where they led various aspects of the company and built relationships with key stakeholders.

John started their career as an Associate Attorney at Fabian & Clendenin and later became a Shareholder (Partner) at the same company. Before that, they held the position of Director of Programming at Quokka.

John Climaco completed their Bachelor of Arts degree in Philosophy at Middlebury College from 1987 to 1991. John then pursued their Juris Doctor (JD) degree in Law at the University of California, Hastings College from 1996 to 2000.